Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

107.42 -1.19 (-1.10%)

Official Closing Price Updated: 7:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

52 53 Next >

Which stocks are moving after the closing bell on Friday? ↗

January 23, 2026

Via Chartmill

Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles

January 23, 2026

Following a resilient performance throughout 2025, healthcare giant Johnson & Johnson (NYSE: JNJ) has officially set its sights on a historic milestone for 2026. In its latest earnings report released...

Via MarketMinute

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

January 23, 2026

Via Chartmill

The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare

January 23, 2026

The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy

Greenland Truces and Intel’s Earnings Bruises: Wall Street’s Identity Crisis ↗

January 23, 2026

Via Chartmill

ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook

January 23, 2026

Healthcare product and device company Abbott Laboratories (NYSE:ABT) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 4.4% year on year to $11.46 billion. Its non-GAAP profit of...

Via StockStory

Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness

January 22, 2026

Abbott Laboratories (NYSE: ABT) saw its stock price tumble by nearly 10% in early trading on January 22, 2026, following the release of its fourth-quarter 2025 financial results. Despite meeting...

Via MarketMinute

Topics Economy

These S&P500 stocks are moving in today's session ↗

January 22, 2026

Via Chartmill

Which S&P500 stocks have an unusual volume on Thursday? ↗

January 22, 2026

Via Chartmill

Abbott Laboratories (NYSE:ABT) Shares Slump on Q4 Revenue Miss and Nutrition Segment Weakness ↗

January 22, 2026

Via Chartmill

Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock for Income Investors ↗

January 17, 2026

Via Chartmill

Why Abbott Laboratories (ABT) Shares Are Sliding Today

January 22, 2026

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.3% in the afternoon session after the company reported fourth-quarter revenue that missed Wall Street's...

Via StockStory

Top S&P500 movers in Thursday's session ↗

January 22, 2026

Via Chartmill

Abbott (ABT) Q4 2025 Earnings Call Transcript ↗

January 22, 2026

Abbott (ABT) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat

January 22, 2026

Abbott Laboratories (NYSE: ABT) saw its shares retreat by 5.8% in early trading on Thursday, January 22, 2026, following the release of its fourth-quarter financial results. Despite delivering an...

Via MarketMinute

Topics Earnings Economy

What's going on in today's session: S&P500 gap up and gap down stocks ↗

January 22, 2026

Via Chartmill

NVE (NVEC) Q3 2026 Earnings Call Transcript ↗

January 22, 2026

NVE (NVEC) Q3 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Supply Chain

Abbott Laboratories (NYSE:ABT) Misses Q4 CY2025 Revenue Estimates, Stock Drops

January 22, 2026

Healthcare product and device company Abbott Laboratories (NYSE:ABT) fell short of the markets revenue expectations in Q4 CY2025 as sales rose 4.4% year on year to $11.46 billion. Its non-GAAP profit...

Via StockStory

Want Decades of Passive Income? 2 Stocks to Buy Right Now. ↗

January 22, 2026

Their dividend streaks speak volumes.

Via The Motley Fool

Topics Artificial Intelligence

Abbott Laboratories (ABT) Q4 Earnings Report Preview: What To Look For

January 21, 2026

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results tomorrow before the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

What To Expect From Abbott Laboratories’s (ABT) Q4 Earnings

January 20, 2026

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Thursday before market open. Here’s what to look for.

Via StockStory

2 Healthcare Names That Could Get a Big Boost From Earnings ↗

January 20, 2026

Via MarketBeat

$5.1 Trillion Global Surge: CEO Confidence Ignites New Era of M&A Transformation

January 19, 2026

The global Mergers and Acquisitions (M&A) market staged a historic comeback in 2025, with total deal value reaching a staggering $5.1 trillion. This resurgence represents a 44% year-over-year increase,...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

January 19, 2026

Income investors can rely on these stocks.

Via The Motley Fool

Topics Intellectual Property

1 Healthcare Stock to Consider Right Now and 2 We Find Risky

January 15, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

Via StockStory

Topics Stocks

The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A

January 14, 2026

As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial...

Via MarketMinute

Topics Artificial Intelligence

The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound

January 13, 2026

For the past two years, the U.S. healthcare sector has been the forgotten stepchild of the equity markets. As the S&P 500 (SPX) surged on the back of an artificial intelligence gold rush and a...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth

January 13, 2026

In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an...

Via MarketMinute

Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability

January 12, 2026

On January 12, 2026, the diagnostic sector witnessed a seismic shift as shares of Biodesix (Nasdaq: BDSX) surged more than 40% in early trading, following the release of preliminary full-year 2025...

Via MarketMinute

Topics Artificial Intelligence Death

Where to Invest $10,000 at the Start of This New Year ↗

January 12, 2026

It's important to diversify and focus on the long term.

Via The Motley Fool

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.